The global demand for Ursodeoxycholic Acid Market is presumed to reach the market size of nearly USD 1419.25 MN by 2030 from USD 605.3 MN in 2022 with a CAGR of 11.24% under the study period 2023 - 2030.
Ursodeoxycholic acid (UDCA), also known as ursodiol, is bile acid naturally found in small quantities in the human body. It is chemically classified as a secondary bile acid and is produced in the liver as a conjugate of chenodeoxycholic acid. This acid plays a crucial role in various physiological processes, particularly in the digestion and absorption of dietary fats. It is widely used in medicine, primarily for its therapeutic properties in the treatment of certain liver and gallbladder conditions.
The Ursodeoxycholic acid (UDCA) market is experiencing growth driven by factors related to its medical applications, particularly in the treatment of liver and gallbladder conditions. Key drivers of this market include the high prevalence of gallstones, as this acid is widely used to non-invasively dissolve cholesterol gallstones. It is also a standard treatment for Primary Biliary Cholangitis (PBC), a liver disease affecting bile ducts, contributing to its growing demand as awareness and diagnosis of PBC increase. Non-alcoholic fatty Liver Disease (NAFLD) is on the rise due to factors like obesity, further highlighting UDCA's potential use in this condition. An increasing emphasis on liver health and the importance of liver function is driving the demand for treatments like ursodeoxycholic acid. The compound's application in addressing liver complications related to cystic fibrosis and pediatric cases, such as biliary atresia in infants, is also contributing to market growth. Research and clinical studies, government approvals, and pharmaceutical companies expanding their product portfolios are fostering interest in UDCA. The aging global population, with its associated higher prevalence of liver and gallbladder conditions, is another driver. Additionally, patient preference for non-invasive treatments is boosting the demand for Ursodeoxycholic acid as a viable alternative to surgical interventions.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ursodeoxycholic acid. The growth and trends of ursodeoxycholic acid industry provide a holistic approach to this study.
This section of the ursodeoxycholic acid market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
By Application
By Mode
By Use
This section covers the regional outlook, which accentuates current and future demand for the Ursodeoxycholic Acid market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Ursodeoxycholic Acid market include ICE S.p.A., Merck KGa, Daewoong Bio, Glenmark Pharmaceuticals Ltd, Dipharma Francis S.r.l., IOL Chemicals and Pharmaceuticals, Kimia Biosciences Ltd, Cerata Pharmaceuticals, Changde Yungang Biotechnology Co. Ltd, Osmopharm SA, Tianjin NWS Biotechnology and Medicine Co. Ltd, Zhongshan Belling Biotechnology Co. Ltd., Axplora, Anant Pharmaceuticals Pvt Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . URSODEOXYCHOLIC ACID – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Mode
3.7.4 Market Attractiveness Analysis By Use
3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL URSODEOXYCHOLIC ACID MARKET ANALYSIS BY TYPE
5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Synthetic Ursodeoxycholic Acid Historic and Forecast Sales by Regions
5.5 Biological Ursodeoxycholic Acid Historic and Forecast Sales by Regions
6 . GLOBAL URSODEOXYCHOLIC ACID MARKET ANALYSIS BY APPLICATION
6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Primary Biliary Cholangitis (PBC) Historic and Forecast Sales by Regions
6.5 Gall Stones Historic and Forecast Sales by Regions
6.6 Other Applications Historic and Forecast Sales by Regions